Is HFFG worth buying
Is it worth buying
Data confidence: high (3/3)
44×0.4 + 40×0.35 + 72×0.25 → 30
HFFG's strength is in the company's own numbers: free cash flow of $1M over the past year — 0% of revenue, and also in the share count: the share count shrank about 0.5% a year.
The weakness is in the technical picture: of 13 technical measures checked, 3 point up and 6 point down, and also in the company's own numbers: the company is still lossmaking — net margin is -3%.
In the background, last quarter 4 of the large holders added and 2 trimmed, and 3 opened a new position, and three or more insiders bought within the same month (10 purchases over 12 months).
So most of the checks are negative together, and in that state a low price is not a reason — it can go lower.
This read changed today.
Computed analysis from public data — not investment advice or a recommendation.
Weaker than the market — lagging the index.-10pp
Market backdrop: Positive market (Risk-On).
Financial health
Leaning negative
44/1003 of 8 checks are positive, 4 negative.
Revenue grew 3% versus the same quarter a year ago, the 10th consecutive growing quarter. The growth rate is slowing. The company is still lossmaking — net margin is -3%. Earnings per share cannot be compared off a negative base. Free cash flow of $1M over the past year — 0% of revenue. This is what is left after every expense and investment.
All the numbers in ProTechnical analysis
Leaning negative
40/1002 of 8 checks are positive, 3 negative.
Of 13 technical measures checked, 3 point up and 6 point down. Price is 9.3% below the 200-day average. Below the long average, the long-term trend is still down. Price is above the 50-day (+6.2%) but below the 200-day (-9.3%). A short-term recovery inside a long-term trend that is still negative.
All the numbers in ProMarket psychology
Leaning positive
72/1005 of 8 checks are positive, 1 negative. (1 checks have no data.)
Last quarter 4 of the large holders added and 2 trimmed, and 3 opened a new position. Three or more insiders bought within the same month (10 purchases over 12 months). Over the past three months the stock lagged the index by 10.1 percentage points.
All the numbers in ProThe company's future
Mixed
50/1000 of 3 checks are positive, 0 negative.
In the last four reports the company beat the earnings estimate 2 times and the revenue estimate 3 times. From the official earnings release filed 2026-08-10, in management's own words: A verbatim quote from a filing with the securities regulator — not our interpretation. The next report is due 2026-11-09. A report is an event that moves the price in both directions.
All the numbers in ProThese are market expectations about the future — not facts or a promise, and they change often.
Next-year earnings estimates moved +0% over the last 3 months.
Estimates are cooling — caution.
~37% growth expected next year · מכפיל רווח עתידי 3.
Most of the future is priced — less room for error.
The price is 215% below the average analyst target.
There is room above according to those covering it — but targets move and often don't come true.
Entry strategy · HFFG
PRO$20/month after the trial · cancel anytime
Bottom line: the company's numbers — leaning negative; the technical picture — leaning negative; and how the market behaves around it — leaning positive. The single largest risk here is that of 13 technical measures checked, 3 point up and 6 point down. What would change the read: Price back above the 200-day average, with the weekly trend lining up behind it.
All data, scores and signals on this page are produced by an automated system and based on technical and quantitative data only. They are not investment advice, investment marketing or a recommendation to act, and are not a substitute for personal advice from a licensed professional. Trading securities involves substantial risk, up to the full loss of your investment; every decision is your sole responsibility.